MMP14 and osteosarcoma: When the MG-63 and Saos-2 osteosarcoma cells were treated with α1-PDX for the indicated times, the expression levels of Wnt and β-catenin decreased significantly, paralleled with the reduction in the MT1-MMP expression levels (Fig. 4).